Eugene Labs closes $3.5M Series A Capital Raise

18 January 2021

Victorian-based health technology company, Eugene Labs (https://eugenelabs.com), has successfully closed a $3.5 million Series A investment round with support from various existing and new investors, including Californian based ALIAVIA Ventures and John McBain (founder of IVF Melbourne) among other industry leaders.

Coghlan Duffy + Co, led by Director, John Coghlan with assistance from Lawyer, Victoria Nadalin, were pleased to act for Eugene Labs on its milestone investment round.

Founded in 2017, Eugene Labs assists its clients in making smarter health choices with their clinical grade at-home genetic tests and digital genetic counselling.

For further information, contact:

John Coghlan | Director
E: jcoghlan@cdandco.com.au

Coghlan Duffy + Co is a boutique corporate and commercial law firm based in Melbourne. The firm is proud to work with an enviable list of clients, including prominent Australian start-ups and ASX-listed companies.

A: Level 42, Rialto South Tower, 525 Collins St VIC 3000
T: +61 3 9614 2444
W: cdandco.com.au